Eli Lilly is making a series of investments in China to support its manufacturing and R&D operations. Gilead Sciences has ...

Weight-loss drugs such as Ozempic, made by Denmark's Novo Nordisk, can reduce rates of opioid and alcohol abuse by up to 50%, according to a new study that supports expectations the drugs can offer ...

Revolutionary weight management and diabetes medications could prove to be the next frontier in addiction recovery treatment medications.

A new study suggests increasingly popular GLP-1 drugs could help cut opioid and alcohol abuse nearly in half. What doesn’t it ...

In a huge new study, researchers have found evidence that drugs like Ozempic can help with alcohol and opioid addiction.

Artificial intelligence can revolutionize drug discovery by expediting development, reducing costs, and improving treatment ...

As an investor in Eli Lilly stock, I'm encouraged by the company's forward thinking. Not only is management making moves to ...

Drugs such as Novo Nordisk’s Ozempic can cut drug and alcohol abuse by up to 50%, a study found, adding to mounting evidence ...

Eli Lilly's valuation could look much more modest in the future, as its earnings should continue to grow at a high rate.

There's no playbook for how to be competitive in artificial intelligence (AI) as a big pharma company, but Eli Lilly (NYSE: ...

Eli Lilly's weight-loss drug is no longer on the Food and Drug Administration's drug shortage list. Compounding pharmacies say this will limit patient access.

INDIANAPOLIS (AP) — Eli Lilly is pouring another $4.5 billion ... Medicine Foundry will allow it to both research new ways of making drugs and build up manufacturing for clinical trials.